Literature DB >> 30363353

Validation of the Parkinson's Disease-Cognitive Rating Scale Applying the Movement Disorder Society Task Force Criteria for Dementia Associated with Parkinson's Disease.

Marcos Serrano-Dueñas1,2, Maite Serrano2, Diana Villena2, David Granda2.   

Abstract

BACKGROUND: The authors studied the measurement properties of the Parkinson's Disease-Cognitive Rating Scale (PD-CRS) compared with Movement Disorders Society Task Force (MDS-TF) criteria for the diagnosis of dementia in patients with Parkinson's disease.
METHODS: The sample consisted of 223 patients who were diagnosed in accordance with the United Kingdom Parkinson's Disease Society Brain Bank who were assessed with both the MDS-TF and the PD-CRS criteria (in addition to other instruments) without the assessors' knowledge of previous results. Internal consistency was studied (homogeneity of the items and Guttmann's λ values were obtained) in addition to convergent, divergent, and discriminative validity. The receiver operating characteristic curve was obtained, and the cutoff point at which the PD-CRS had the greatest efficiency was analyzed.
RESULTS: The internal consistency was shown to be adequate, with a λ value of 0.821. A floor effect was observed in 4 of the items (Sustained Attention, Working Memory, Immediate Verbal Memory, and Alternating Verbal Fluency), and 1 item showed a ceiling effect (Clock Copying). The scale adequately discriminated patients with and without dementia (Kruskal-Wallis; P ≤ 0.000). The area under the curve was 0.899. With a cutoff score of 62 (from a possible score of 134), the scale achieved 94% sensitivity and 99% specificity.
CONCLUSIONS: The PD-CRS has adequate measurement properties and is a valid tool for studying the presence of dementia in patients with Parkinson's disease.

Entities:  

Keywords:  Parkinson's Disease Cognitive Rating Scale (PD‐CRS); Parkinson's disease; cognitive deterioration; validation

Year:  2016        PMID: 30363353      PMCID: PMC6174395          DOI: 10.1002/mdc3.12338

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN: 2330-1619


  33 in total

1.  Validating a quality of life rating scale for idiopathic parkinsonism: Parkinson's Impact Scale (PIMS).

Authors:  S Calne; M Schulzer; E Mak; C Guyette; G Rohs; S Hatchard; D Murphy; J Hodder; C Gagnon; S Weatherby; L Beaudet; J Duff; S Pegler
Journal:  Parkinsonism Relat Disord       Date:  1996-04       Impact factor: 4.891

2.  Dementia associated with Parkinson's disease: applying the Movement Disorder Society Task Force criteria.

Authors:  P Martinez-Martin; C Falup-Pecurariu; C Rodriguez-Blazquez; M Serrano-Dueñas; F J Carod Artal; J M Rojo Abuin; D Aarsland
Journal:  Parkinsonism Relat Disord       Date:  2011-06-30       Impact factor: 4.891

Review 3.  A systematic review of prevalence studies of dementia in Parkinson's disease.

Authors:  Dag Aarsland; Julia Zaccai; Carol Brayne
Journal:  Mov Disord       Date:  2005-10       Impact factor: 10.338

Review 4.  Psychometric considerations in evaluating health-related quality of life measures.

Authors:  R D Hays; R Anderson; D Revicki
Journal:  Qual Life Res       Date:  1993-12       Impact factor: 4.147

5.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

Review 6.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

Authors:  W R Gibb; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

7.  A simplified algorithm may lead to overestimate dementia in PD. A clinical and epidemiological study using criteria for PD-D proposed by the Movement Disorders Task Force.

Authors:  M E Di Battista; P Giustini; S Bernardi; P Stirpe; N Vanacore; Giuseppe Meco
Journal:  J Neural Transm (Vienna)       Date:  2011-04-10       Impact factor: 3.575

8.  Parkinson's disease-cognitive rating scale: psychometrics for mild cognitive impairment.

Authors:  Ramón Fernández de Bobadilla; Javier Pagonabarraga; Saül Martínez-Horta; Berta Pascual-Sedano; Antonia Campolongo; Jaime Kulisevsky
Journal:  Mov Disord       Date:  2013-07-19       Impact factor: 10.338

Review 9.  Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force.

Authors:  Bruno Dubois; David Burn; Christopher Goetz; Dag Aarsland; Richard G Brown; Gerald A Broe; Dennis Dickson; Charles Duyckaerts; Jefferey Cummings; Serge Gauthier; Amos Korczyn; Andrew Lees; Richard Levy; Irene Litvan; Yoshikuni Mizuno; Ian G McKeith; C Warren Olanow; Werner Poewe; Cristina Sampaio; Eduardo Tolosa; Murat Emre
Journal:  Mov Disord       Date:  2007-12       Impact factor: 10.338

10.  Validation of the Italian version of Parkinson's disease-cognitive rating scale (PD-CRS).

Authors:  Gabriella Santangelo; Paolo Barone; Giovanni Abbruzzese; Luigi Ferini-Strambi; Angelo Antonini
Journal:  Neurol Sci       Date:  2013-09-25       Impact factor: 3.307

View more
  5 in total

1.  Parkinson's Disease Gravity Index: A Method by means of Optimal Scaling.

Authors:  Marcos Serrano-Dueñas; Luis Masabanda; Maria-Rosario Luquin
Journal:  Neurol Res Int       Date:  2020-12-15

2.  Gamified Dual-Task Training for Individuals with Parkinson Disease: An Exploratory Study on Feasibility, Safety, and Efficacy.

Authors:  Lee-Kuen Chua; Yu-Chen Chung; David Bellard; Laura Swan; Nicole Gobreial; Amanda Romano; Ryan Glatt; Michael A Bonaguidi; Darrin J Lee; Yi Jin; Charles Y Liu; Beth E Fisher
Journal:  Int J Environ Res Public Health       Date:  2021-11-25       Impact factor: 3.390

3.  Plasma Levels of α-Synuclein, Aβ-40 and T-tau as Biomarkers to Predict Cognitive Impairment in Parkinson's Disease.

Authors:  Nai-Ching Chen; Hsiu-Ling Chen; Shau-Hsuan Li; Yen-Hsiang Chang; Meng-Hsiang Chen; Nai-Wen Tsai; Chiun-Chieh Yu; Shieh-Yueh Yang; Cheng-Hsien Lu; Wei-Che Lin
Journal:  Front Aging Neurosci       Date:  2020-04-28       Impact factor: 5.750

4.  Validation of Revised Chinese Version of PD-CRS in Parkinson's Disease Patients.

Authors:  Yuyan Tan; Weiguo Liu; Juanjuan Du; Miaomiao Hou; Cuiyu Yu; Yang Liu; Shishuang Cui; Lei Yan; Yizhou Lu; Hong Lv; Lijun Han; Xi Wang; Shengyu Zha; Xiaoguang Luo; Huidong Tang; Shengdi Chen
Journal:  Parkinsons Dis       Date:  2020-02-19

5.  Prevalence of Fabry Disease among Patients with Parkinson's Disease.

Authors:  Alexandra Lackova; Christian Beetz; Sebastian Oppermann; Peter Bauer; Petra Pavelekova; Tatiana Lorincova; Miriam Ostrozovicova; Kristina Kulcsarova; Jana Cobejova; Martin Cobej; Petra Levicka; Simona Liesenerova; Daniela Sendekova; Viktoria Sukovska; Zuzana Gdovinova; Vladimir Han; Mie Rizig; Henry Houlden; Matej Skorvanek
Journal:  Parkinsons Dis       Date:  2022-01-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.